178 related articles for article (PubMed ID: 23606133)
1. Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks.
Ljubisavljevic S; Stojanovic I; Vojinovic S; Milojkovic M; Dunjic O; Stojanov D; Pavlovic D
Metab Brain Dis; 2013 Dec; 28(4):629-38. PubMed ID: 23606133
[TBL] [Abstract][Full Text] [Related]
2. The treatment of multiple sclerosis with inosine.
Markowitz CE; Spitsin S; Zimmerman V; Jacobs D; Udupa JK; Hooper DC; Koprowski H
J Altern Complement Med; 2009 Jun; 15(6):619-25. PubMed ID: 19425822
[TBL] [Abstract][Full Text] [Related]
3. Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation.
Ljubisavljevic S; Stojanovic I; Cvetkovic T; Vojinovic S; Stojanov D; Stojanovic D; Stefanovic N; Pavlovic D
J Neurol Sci; 2014 Feb; 337(1-2):8-13. PubMed ID: 24269090
[TBL] [Abstract][Full Text] [Related]
4. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
Teunissen CE; Sombekke M; van Winsen L; Killestein J; Barkhof F; Polman CH; Dijkstra CD; Blankenstein MA; Pratico D
Mult Scler; 2012 Aug; 18(8):1092-8. PubMed ID: 22695538
[TBL] [Abstract][Full Text] [Related]
5. Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis.
Yu CS; Lin FC; Liu Y; Duan Y; Lei H; Li KC
Eur J Radiol; 2008 Nov; 68(2):328-34. PubMed ID: 17928182
[TBL] [Abstract][Full Text] [Related]
6. The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2'-deoxyguanosine as Plasma Biomarkers of Clinical/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks.
Ljubisavljevic S; Stojanovic I; Basic J; Pavlovic DA
Neurotox Res; 2016 Oct; 30(3):530-8. PubMed ID: 27295058
[TBL] [Abstract][Full Text] [Related]
7. Serum uric acid and multiple sclerosis.
Rentzos M; Nikolaou C; Anagnostouli M; Rombos A; Tsakanikas K; Economou M; Dimitrakopoulos A; Karouli M; Vassilopoulos D
Clin Neurol Neurosurg; 2006 Sep; 108(6):527-31. PubMed ID: 16202511
[TBL] [Abstract][Full Text] [Related]
8. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Al-Radaideh A; Mougin OE; Lim SY; Chou IJ; Constantinescu CS; Gowland P
NMR Biomed; 2015 Nov; 28(11):1374-82. PubMed ID: 26346925
[TBL] [Abstract][Full Text] [Related]
9. Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
Moccia M; Lanzillo R; Costabile T; Russo C; Carotenuto A; Sasso G; Postiglione E; De Luca Picione C; Vastola M; Maniscalco GT; Palladino R; Brescia Morra V
J Neurol; 2015; 262(4):961-7. PubMed ID: 25673130
[TBL] [Abstract][Full Text] [Related]
10. Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
Haider L; Prados F; Chung K; Goodkin O; Kanber B; Sudre C; Yiannakas M; Samson RS; Mangesius S; Thompson AJ; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Chard DT; Barkhof F
Brain; 2021 Jun; 144(5):1384-1395. PubMed ID: 33880511
[TBL] [Abstract][Full Text] [Related]
11. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.
Dalton CM; Bodini B; Samson RS; Battaglini M; Fisniku LK; Thompson AJ; Ciccarelli O; Miller DH; Chard DT
Mult Scler; 2012 Mar; 18(3):322-8. PubMed ID: 21878451
[TBL] [Abstract][Full Text] [Related]
12. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Hofstetter L; Naegelin Y; Filli L; Kuster P; Traud S; Smieskova R; Mueller-Lenke N; Kappos L; Gass A; Sprenger T; Penner IK; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
Mult Scler; 2014 Feb; 20(2):202-13. PubMed ID: 23804554
[TBL] [Abstract][Full Text] [Related]
13. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
Rudick RA; Lee JC; Nakamura K; Fisher E
J Neurol Sci; 2009 Jul; 282(1-2):106-11. PubMed ID: 19100997
[TBL] [Abstract][Full Text] [Related]
14. Serum uric acid level in patients with relapsing-remitting multiple sclerosis.
Ashtari F; Bahar M; Aghaei M; Zahed A
J Clin Neurosci; 2013 May; 20(5):676-8. PubMed ID: 23528410
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
[TBL] [Abstract][Full Text] [Related]
16. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
[TBL] [Abstract][Full Text] [Related]
17. Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction.
Toncev G; Milicic B; Toncev S; Samardzic G
Eur J Neurol; 2002 May; 9(3):221-6. PubMed ID: 11985629
[TBL] [Abstract][Full Text] [Related]
18. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
[TBL] [Abstract][Full Text] [Related]
19. The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in plasma and CSF.
Ljubisavljevic S; Stojanovic I; Vojinovic S; Stojanov D; Stojanovic S; Cvetkovic T; Savic D; Pavlovic D
Neurochem Int; 2013 Jun; 62(7):988-97. PubMed ID: 23500606
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid levels in patients with multiple sclerosis: a meta-analysis.
Liu B; Shen Y; Xiao K; Tang Y; Cen L; Wei J
Neurol Res; 2012 Mar; 34(2):163-71. PubMed ID: 22333889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
